The state-of-the art cGMP facility will have latest technologies implemented in its manufacturing area
Ideal Cures announced the addition of its fourth manufacturing location at Sikkim. It will supply best-in-class products for not only the pharmaceutical and allied industries in the region, but also will expand its customer base globally. Ideal Cures, with all its plants EXCiPACT certified, is all set to bring its latest facility, which is presently under construction. It will be operational in the first quarter of 2017.
The state-of-the art cGMP facility will have latest technologies implemented in its manufacturing area and will be certified like the other plants.
Suresh Pareek, MD, Ideal Cures said, “Our business is customer centric and I am pleased to share with you that our customers who have their plants in Sikkim are happy to see that availability of coating material will be faster.”
Dr Kamlesh Oza, President Global Business Development, Ideal Cures said, “Ideal Cures is walking the talk with this significant strategic investment to show solidarity and unparalleled commitment to its customers in the region and globally.”
EP News Bureau